| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |